UBS Maintains Neutral on CME Group, Raises Price Target to $270
UBS analyst Alex Kramm maintains CME Group (NASDAQ:CME) with a Neutral and raises the price target from $260 to $270.
Stocks · News reference
Today, CME Group provided the following statement about its plans to suspend launch of a new 10-Barrel Crude Oil futures contract:"Providing efficient, regulated markets that allow our clients to cost-effectively
Reference Details
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
Keep reading
UBS analyst Alex Kramm maintains CME Group (NASDAQ:CME) with a Neutral and raises the price target from $260 to $270.
TD Cowen analyst Bill Katz maintains CME Group (NASDAQ:CME) with a Buy and raises the price target from $292 to $300.